Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13 (2021)
- Authors:
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.3389/fnmol.2021.673144
- Subjects: ESQUIZOFRENIA; ANTIPSICÓTICOS; LINHAGEM CELULAR; PROTEÔMICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Molecular Neuroscience
- ISSN: 1662-5099
- Volume/Número/Paginação/Ano: v. 14, art. 673144, 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FALVELLA, Ana Caroline Brambilla et al. Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13. Frontiers in Molecular Neuroscience, v. 14, 2021Tradução . . Disponível em: https://doi.org/10.3389/fnmol.2021.673144. Acesso em: 10 fev. 2026. -
APA
Falvella, A. C. B., Smith, B. J., Silva-Costa, L. C., Valença, A. G. F., Crunfli, F., Zuardi, A. W., et al. (2021). Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13. Frontiers in Molecular Neuroscience, 14. doi:10.3389/fnmol.2021.673144 -
NLM
Falvella ACB, Smith BJ, Silva-Costa LC, Valença AGF, Crunfli F, Zuardi AW, Hallak JEC, Crippa JA de S, Almeida V de, Martins-de Souza D. Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13 [Internet]. Frontiers in Molecular Neuroscience. 2021 ; 14[citado 2026 fev. 10 ] Available from: https://doi.org/10.3389/fnmol.2021.673144 -
Vancouver
Falvella ACB, Smith BJ, Silva-Costa LC, Valença AGF, Crunfli F, Zuardi AW, Hallak JEC, Crippa JA de S, Almeida V de, Martins-de Souza D. Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13 [Internet]. Frontiers in Molecular Neuroscience. 2021 ; 14[citado 2026 fev. 10 ] Available from: https://doi.org/10.3389/fnmol.2021.673144 - Cannabidiol and neuroprotection: evidence from preclinical studies
- Marijuana, feijoada and the debate on drug legalization
- Cannabidiol for the treatment of psychosis in Parkinson's disease
- Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion
- Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy
Informações sobre o DOI: 10.3389/fnmol.2021.673144 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
